(2022) Acquired hemophilia in a patient with SARS-CoV-2 infection; a case report. Journal of Nephropharmacology. ISSN 23454202 (ISSN)
Full text not available from this repository.
Abstract
Acquired hemophilia (AH) is a potentially life-threatening hemorrhagic disorder. We report the second confirmed case of COVID-19-associated AH in a 45-year-old female which, unfortunately, expired as her treatment failed. She presented to the emergency department with abnormal bleeding and spontaneous hemoptysis about ten days after a removal surgery of her epiglottis tumor. Aggregation tests, such as partial thromboplastin time (PTT), are recommended in patients with COVID-19 infection that have bleeding episodes. © 2022 The Author(s); Published by Society of Diabetic Nephropathy Prevention.
| Item Type: | Article |
|---|---|
| Keywords: | Acquired hemophilia COVID-19 Partial thromboplastin time |
| Journal or Publication Title: | Journal of Nephropharmacology |
| Journal Index: | Scopus |
| Volume: | 11 |
| Number: | 2 |
| Identification Number: | https://doi.org/10.34172/npj.2022.10453 |
| ISSN: | 23454202 (ISSN) |
| Depositing User: | Zahra Otroj |
| URI: | http://eprints.mui.ac.ir/id/eprint/16954 |
Actions (login required)
 |
View Item |